Todd Michael Wood Derm Tech, Inc. (DMTK) insider trading activity

Todd Michael Wood is Chief Commercial Officer of DermTech, Inc.. Currently has a direct ownership of 284,757 shares of DMTK, which is worth approximately $19,932. The most recent transaction as insider was on Jun 12, 2023, when has been sold 350 shares (Common Stock) at a price of $2.85 per share, resulting in proceeds of $997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 285K

0% 3M change

0% 12M change

Total Value Held $19,932

Todd Michael Wood Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 12 2023	SELL Open market or private sale	$997 $2.85 p/Share	350 Reduced 0.12%	284,757 Common Stock
Jun 07 2023	SELL Open market or private sale	$12,629 $2.53 p/Share	4,992 Reduced 1.72%	285,107 Common Stock
Mar 13 2023	SELL Open market or private sale	$1,343 $3.26 p/Share	412 Reduced 0.14%	290,099 Common Stock
Mar 07 2023	SELL Open market or private sale	$35,374 $4.06 p/Share	8,713 Reduced 4.07%	205,397 Common Stock
Mar 07 2023	BUY Grant, award, or other acquisition	-	85,114 Added 22.66%	290,511 Common Stock
Dec 12 2022	SELL Open market or private sale	$790 $2.22 p/Share	356 Reduced 0.17%	214,110 Common Stock
Dec 08 2022	SELL Open market or private sale	$1,039 $2.32 p/Share	448 Reduced 0.21%	214,466 Common Stock

Dec 06 2022	SELL Open market or private sale	$451 $2.44 p/Share	185 Reduced 0.09%	214,914 Common Stock
Sep 12 2022	SELL Open market or private sale	$2,096 $5.99 p/Share	350 Reduced 0.16%	215,099 Common Stock
Sep 08 2022	SELL Open market or private sale	$2,452 $5.65 p/Share	434 Reduced 0.2%	215,449 Common Stock
Sep 06 2022	SELL Open market or private sale	$983 $5.43 p/Share	181 Reduced 0.08%	215,883 Common Stock
Jun 13 2022	SELL Open market or private sale	$1,804 $4.81 p/Share	375 Reduced 0.17%	216,064 Common Stock
Jun 08 2022	SELL Open market or private sale	$2,711 $6.26 p/Share	433 Reduced 0.2%	216,439 Common Stock
Jun 06 2022	SELL Open market or private sale	$1,166 $6.48 p/Share	180 Reduced 0.08%	216,872 Common Stock
Mar 23 2022	BUY Grant, award, or other acquisition	-	75,215 Added 25.74%	217,052 Common Stock
Mar 11 2022	SELL Open market or private sale	$5,063 $14.55 p/Share	348 Reduced 0.24%	141,837 Common Stock
Mar 08 2022	SELL Open market or private sale	$5,296 $12.64 p/Share	419 Reduced 0.29%	142,185 Common Stock
Mar 07 2022	SELL Open market or private sale	$9,095 $13.03 p/Share	698 Reduced 0.49%	142,604 Common Stock
Dec 14 2021	SELL Open market or private sale	$10,377 $16.29 p/Share	637 Reduced 0.44%	143,302 Common Stock
Dec 13 2021	SELL Open market or private sale	$19,283 $16.71 p/Share	1,154 Reduced 0.8%	143,939 Common Stock
Dec 08 2021	SELL Open market or private sale	$7,864 $18.46 p/Share	426 Reduced 0.29%	145,093 Common Stock
Sep 14 2021	SELL Open market or private sale	$22,754 $35.06 p/Share	649 Reduced 0.44%	145,519 Common Stock
Sep 13 2021	SELL Open market or private sale	$40,750 $36.19 p/Share	1,126 Reduced 0.76%	146,168 Common Stock
Sep 08 2021	SELL Open market or private sale	$15,992 $36.18 p/Share	442 Reduced 0.3%	147,294 Common Stock
Jun 14 2021	SELL Open market or private sale	$107,563 $41.53 p/Share	2,590 Reduced 1.72%	147,736 Common Stock

Also insider at

ALIM

ALIMERA SCIENCES INC Healthcare

President of U.S. Operations

TMW